Cargando…
Targeting prostate cancer with radiolabelled bombesins
The fact that a number of common human tumours, including those of breast and prostate, express increased levels of the gastrin-releasing peptide receptor (GRP-R) means that this receptor is a potential target for peptide receptor mediated scintigraphy and targeted radionuclide therapy. Although cli...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-MED
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693771/ https://www.ncbi.nlm.nih.gov/pubmed/17098646 http://dx.doi.org/10.1102/1470-7330.2006.0025 |